BridgeBio have significantly improved the progress of the innovative treatment for ATTR-CM, employing the compound. Preliminary clinical data suggests significant improvements for individuals diagnosed from the severe https://biotech439187.dailyhitblog.com/47785836/firm-improves-amyloidosis-management-through-the-drug